Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Edelman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of the National Medical Association|April 21, 2007
New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogsCharles Choe, Steve Edelman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 13, 2008
Pramlintide in the treatment of diabetes mellitusSteve Edelman, Holly Maier, Ken Wilhelm
Diabetes, Obesity & Metabolism|July 19, 2017
Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative surveyLori Berard, Mireille Bonnemaire, Marie Mical, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based StudyUdo Stauder, Diplom Enginee, Hina Elton, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 26, 2024
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital TechnologySteve Edelman, Wayman W Cheatham, Anna Norton, et al.
The American Journal of Managed Care|August 15, 2024
Inadequate insurance coverage for overweight/obesity managementEden Miller, Steve Edelman, Carlos Campos, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Impact of Biosimilar Insulins on Clinical Practice: Meeting ReportRichard O Dolinar, Steve Edelman, Lutz Heinemann, et al.
Pharmacoeconomics - Open|January 31, 2020
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the USSteve Edelman, Fang Liz Zhou, Ronald Preblick, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 4, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 27, 2020
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the National Medical Association|April 21, 2007
New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogsCharles Choe, Steve Edelman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 13, 2008
Pramlintide in the treatment of diabetes mellitusSteve Edelman, Holly Maier, Ken Wilhelm
Diabetes, Obesity & Metabolism|July 19, 2017
Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative surveyLori Berard, Mireille Bonnemaire, Marie Mical, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based StudyUdo Stauder, Diplom Enginee, Hina Elton, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 26, 2024
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital TechnologySteve Edelman, Wayman W Cheatham, Anna Norton, et al.
The American Journal of Managed Care|August 15, 2024
Inadequate insurance coverage for overweight/obesity managementEden Miller, Steve Edelman, Carlos Campos, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Impact of Biosimilar Insulins on Clinical Practice: Meeting ReportRichard O Dolinar, Steve Edelman, Lutz Heinemann, et al.
Pharmacoeconomics - Open|January 31, 2020
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the USSteve Edelman, Fang Liz Zhou, Ronald Preblick, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 4, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 27, 2020
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study DesignTadej Battelino, Zsolt Bosnyak, Thomas Danne, et al.
Pageof 2